Quantcast
Last updated on April 17, 2014 at 13:45 EDT

Latest autoimmune diseases Stories

2013-08-28 08:25:58

Detailed Results from "RA in America" Available on Newly Launched Website RheumatoidArthritis.Net PHILADELPHIA, Aug. 28, 2013 /PRNewswire/ -- Health Union, LLC announced today that it has published detailed results from the "RA in America 2013" survey on its newly launched website http://RheumatoidArthritis.Net. The survey covered a broad array of topics impacting people with Rheumatoid Arthritis (also called RA), and was taken by 1,055 respondents making it one of the largest of its...

2013-08-27 23:23:16

This EpiCast report (http://www.reportsnreports.com/reports/267627-epicast-report-systemic-lupus-erythematosus-epidemiology-forecast-to-2022.html ) says Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. Dallas, Texas (PRWEB) August 27, 2013 The...

2013-08-27 20:22:42

CAMBRIDGE, Mass., Aug. 27, 2013 /PRNewswire/ -- Researchers have developed a new approach to detecting unrecognized cases of celiac disease in the community, revealing this immune disorder is far more common than previously recognized. In a study of more than 2500 adults, the researchers combined traditional antibody testing (measuring the immune response to gluten) with an assessment of specific genetic risk markers. They found that more than half of the subjects had genetic risk...

2013-08-26 10:36:50

Model including dozens of mutations helps clarify genetic factors involved in Crohn's disease A statistical model accounting for dozens of different genes in combination—and the interactions between them—is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD), reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams...

2013-08-26 00:20:28

Common Stock Trading on Nasdaq OMX Stockholm Exchange and OTCQX Trading Platform TARRYTOWN, N.Y., Aug. 26, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq OMX Stockholm Exchange: IMNP and OTCQX: EPCTD) (the "Company") announced today the completion of the merger of Immune Pharmaceuticals Ltd. and EpiCept Corporation. The merger combines Immune's antibody therapeutic platform focused on the treatment of inflammatory diseases and cancer with EpiCept's early stage cancer...

2013-08-23 04:20:26

MANCHESTER, England, August 23, 2013 /PRNewswire/ -- With autumn fast approaching it is time for a lot of people to start gearing up for the party season. The team at HAIR SOLVED [http://www.hair-solved.com ] are excited about all the great events brought by the transition from summer to autumn and they are encouraging all women to feel the same - even if they are affected by hair loss. Hair loss is a more prevalent issue among women than most people are aware. Studies...

2013-08-22 12:52:15

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM). William Sandborn, MD, principal investigator of the Crohn's disease study, said the results offer new hope to the more than one million Americans...

2013-08-21 16:24:49

OSAKA, Japan, Aug. 21, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that results from two Phase 3 studies evaluating vedolizumab, an investigational humanized monoclonal antibody, for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), were published in the August 22, 2013 issue of the New England Journal of Medicine. Chronic and debilitating diseases, CD and UC are the two most common...

2013-08-21 08:26:09

ORMD-0801 US FDA trial for the treatment of type 2 diabetes is already in progress JERUSALEM, August 21, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has initiated patient recruitment for a new clinical trial of its orally ingestible insulin capsule, ORMD-0801 for patients with type 1 diabetes mellitus (T1DM) in Israel. "We are very excited to continue our...

2013-08-20 23:01:04

DailyGossip.org reviews one of the newest and most efficient vitiligo natural treatments at the moment, the Natural Vitiligo Treatment System. (PRWEB) August 20, 2013 According to the Natural Vitiligo Treatment System published by http://www.DailyGossip.org on August 21, this new treatment developed by Michael Dawson is effective and it will actually lead to the cure of vitiligo in just 2 months. The Natural Vitiligo Treatment System review explains that Michael Dawson’s method...